September 20, 2019 M&A, Partnerships

Aiming to Increase Quality and Efficiency in Complex Vacuum Coating Applications

HORIBA and Socrate Industrie work together on closed-loop process and control technologies that stand to ensure coating thickness uniformity and composition, plus reduce waste. Northampton, United Kingdom – HORIBA, the world-renowned manufacturer of high-quality instruments and measurement systems, is collaborating with Socrate Industrie in process and control technologies that stand to improve quality and yield in vacuum coating applications... Read more

September 19, 2019 M&A, Partnerships

Divestment of BTG

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION 19 September 2019 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has agreed with Voith GmbH & Co. KGaA (‘Voith’) for Voith to acquire BTG Group (‘BTG’) from Spectris for a total gross cash consideration of €319 million (£283 million). The sale... Read more

September 18, 2019 Clinical Research/Diagn. M&A, Partnerships

BD partners with global organizations to support diagnostic testing for AMR

Sep 18, 2019 For the third time in five years, Fortune has named BD to its list of companies that are Changing the World , this year recognizing the company for its significant global efforts and investments to combat antimicrobial resistance (AMR) in the areas of infection prevention, diagnostics, surveillance and reporting. Through its decades of experience in collaborating to... Read more

September 11, 2019 Clinical Research/Diagn. M&A, Partnerships

FOSS and Technical University of Denmark enter partnership

HILLERØD, 11. September, 2019. FOSS and DTU, Technical University of Denmark, join forces around common interests within research, development and education. A new strategic partnership between DTU and FOSS will strengthen the existing relations within research, development and education. The aim is to create a platform for common projects and goals, and to ensure a... Read more

September 11, 2019 M&A, Partnerships

GE Healthcare and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing

Marlborough, MA, United States and Dublin, Ireland – September 11, 2019 – GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are combining their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing. As part of the collaboration, GE Healthcare and NIBRT will share... Read more

September 10, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories

San Jose, Calif. – (September 3, 2019) – Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together... Read more

September 9, 2019 Clinical Research/Diagn. M&A, Partnerships PR/Corporate

Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer

9 September 2019, Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.... Read more

September 9, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor

Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered non-small cell lung cancer and thyroid cancer patients who may be suitable for LOXO-292, Lilly’s RET inhibitor CARLSBAD, Calif., Sept. 9, 2019 /PRNewswire/ — Thermo... Read more

September 5, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships Microscopy

European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases

MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology has been selected by the European research program SOLVE-RD to help reveal the genetic mechanisms responsible for rare genetic... Read more